Annual EBITDA:
-$677.70M-$199.82M(-41.82%)Summary
- As of today, RVMD annual EBITDA is -$677.70 million, with the most recent change of -$199.82 million (-41.82%) on December 31, 2024.
- During the last 3 years, RVMD annual EBITDA has fallen by -$497.95 million (-277.03%).
- RVMD annual EBITDA is now -2171.42% below its all-time high of -$29.84 million, reached on December 31, 2017.
Performance
RVMD EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$310.93M-$50.02M(-19.17%)Summary
- As of today, RVMD quarterly EBITDA is -$310.93 million, with the most recent change of -$50.02 million (-19.17%) on September 30, 2025.
- Over the past year, RVMD quarterly EBITDA has dropped by -$138.09 million (-79.89%).
- RVMD quarterly EBITDA is now -3124.42% below its all-time high of -$9.64 million, reached on March 31, 2019.
Performance
RVMD Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$1.02B-$138.09M(-15.63%)Summary
- As of today, RVMD TTM EBITDA is -$1.02 billion, with the most recent change of -$138.09 million (-15.63%) on September 30, 2025.
- Over the past year, RVMD TTM EBITDA has dropped by -$379.90 million (-59.18%).
- RVMD TTM EBITDA is now -9559.77% below its all-time high of -$10.58 million, reached on December 31, 2018.
Performance
RVMD TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
RVMD EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -41.8% | -79.9% | -59.2% |
| 3Y3 Years | -277.0% | -319.6% | -325.1% |
| 5Y5 Years | -1294.8% | -1099.5% | -1029.4% |
RVMD EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -277.0% | at low | -426.0% | at low | -325.1% | at low |
| 5Y | 5-Year | -1294.8% | at low | -1099.5% | at low | -1029.4% | at low |
| All-Time | All-Time | -2171.4% | at low | -3124.4% | at low | -9559.8% | at low |
RVMD EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$310.93M(-19.2%) | -$1.02B(-15.6%) |
| Jun 2025 | - | -$260.91M(-10.1%) | -$883.72M(-13.8%) |
| Mar 2025 | - | -$237.04M(-11.3%) | -$776.66M(-14.6%) |
| Dec 2024 | -$677.70M(-41.8%) | -$212.92M(-23.2%) | -$677.71M(-5.6%) |
| Sep 2024 | - | -$172.84M(-12.3%) | -$641.91M(-8.8%) |
| Jun 2024 | - | -$153.85M(-11.4%) | -$590.17M(-8.6%) |
| Mar 2024 | - | -$138.10M(+22.0%) | -$543.35M(-13.7%) |
| Dec 2023 | -$477.88M(-92.2%) | -$177.13M(-46.3%) | -$477.88M(-32.8%) |
| Sep 2023 | - | -$121.10M(-13.2%) | -$359.86M(-15.0%) |
| Jun 2023 | - | -$107.02M(-47.4%) | -$312.86M(-17.8%) |
| Mar 2023 | - | -$72.62M(-22.9%) | -$265.59M(-6.8%) |
| Dec 2022 | -$248.62M | -$59.11M(+20.2%) | -$248.62M(-3.4%) |
| Sep 2022 | - | -$74.10M(-24.0%) | -$240.37M(-10.4%) |
| Jun 2022 | - | -$59.76M(-7.4%) | -$217.68M(-8.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$55.66M(-9.5%) | -$200.62M(-11.0%) |
| Dec 2021 | -$179.75M(-76.4%) | -$50.85M(+1.1%) | -$180.68M(-11.4%) |
| Sep 2021 | - | -$51.41M(-20.4%) | -$162.21M(-18.6%) |
| Jun 2021 | - | -$42.69M(-19.5%) | -$136.71M(-13.6%) |
| Mar 2021 | - | -$35.72M(-10.3%) | -$120.33M(-15.5%) |
| Dec 2020 | -$101.91M(-109.7%) | -$32.38M(-24.9%) | -$104.15M(-15.1%) |
| Sep 2020 | - | -$25.92M(+1.5%) | -$90.47M(-17.1%) |
| Jun 2020 | - | -$26.31M(-34.7%) | -$77.24M(-27.3%) |
| Mar 2020 | - | -$19.54M(-4.5%) | -$60.67M(-19.5%) |
| Dec 2019 | -$48.59M(-21.7%) | -$18.70M(-47.4%) | -$50.78M(-19.0%) |
| Sep 2019 | - | -$12.69M(-30.1%) | -$42.66M(-42.3%) |
| Jun 2019 | - | -$9.75M(-1.1%) | -$29.97M(-48.2%) |
| Mar 2019 | - | -$9.64M(+8.8%) | -$20.22M(-91.2%) |
| Dec 2018 | -$39.91M(-33.8%) | -$10.58M | -$10.58M |
| Dec 2017 | -$29.84M | - | - |
FAQ
- What is Revolution Medicines, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Revolution Medicines, Inc.?
- What is Revolution Medicines, Inc. annual EBITDA year-on-year change?
- What is Revolution Medicines, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Revolution Medicines, Inc.?
- What is Revolution Medicines, Inc. quarterly EBITDA year-on-year change?
- What is Revolution Medicines, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Revolution Medicines, Inc.?
- What is Revolution Medicines, Inc. TTM EBITDA year-on-year change?
What is Revolution Medicines, Inc. annual EBITDA?
The current annual EBITDA of RVMD is -$677.70M
What is the all-time high annual EBITDA for Revolution Medicines, Inc.?
Revolution Medicines, Inc. all-time high annual EBITDA is -$29.84M
What is Revolution Medicines, Inc. annual EBITDA year-on-year change?
Over the past year, RVMD annual EBITDA has changed by -$199.82M (-41.82%)
What is Revolution Medicines, Inc. quarterly EBITDA?
The current quarterly EBITDA of RVMD is -$310.93M
What is the all-time high quarterly EBITDA for Revolution Medicines, Inc.?
Revolution Medicines, Inc. all-time high quarterly EBITDA is -$9.64M
What is Revolution Medicines, Inc. quarterly EBITDA year-on-year change?
Over the past year, RVMD quarterly EBITDA has changed by -$138.09M (-79.89%)
What is Revolution Medicines, Inc. TTM EBITDA?
The current TTM EBITDA of RVMD is -$1.02B
What is the all-time high TTM EBITDA for Revolution Medicines, Inc.?
Revolution Medicines, Inc. all-time high TTM EBITDA is -$10.58M
What is Revolution Medicines, Inc. TTM EBITDA year-on-year change?
Over the past year, RVMD TTM EBITDA has changed by -$379.90M (-59.18%)